RingConn Smart Ring Impresses at CES 2024: Unveiling Plans on Features and Medical Algorithms Updates that Redefine Personal Health Management The RingConn booth in LVCC North Hall was a buzz of activity, drawing attention from 100+ top-tier media outlets and influencers. This acclaim was paralleled by the interest of the diverse CES audience, many of … Read more
Discover the future of Enterprise Imaging with Apollo’s approach at RSNA Booth 6810, Nov. 26-29, 2023 CHICAGO, Nov. 25, 2023 /PRNewswire/ — Apollo, a leading provider of enterprise imaging solutions and an Amazon Web Services (AWS) Public Sector Partner (PSP) Program Member, today introduced a new eBook titled Delivering relevant medical images across the continuum … Read more
Updated data from the Phase I trial of RVU120 in relapsed/refractory acute myeloid leukemia (r/r AML) or high-risk myelodysplastic syndromes (HR-MDS) demonstrate clinically relevant benefit in 50% of evaluable patients Preclinical data support RVU120 as a novel agent for the treatment of patients with lower-risk MDS (LR-MDS) and show cytotoxic and differentiating effects on leukemic stem cells … Read more
Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and simultaneously published in The New England Journal of Medicine MADRID, Oct. 21, 2023 /PRNewswire/ — … Read more
– Congreso Anual 2023 de la Academia Europea de Alergia e Inmunología Clínica (EAACI): Concluye con éxito, estableciendo nuevos hitos en alergia e inmunología clínica HAMBURGO, Alemania, 13 de junio de 2023 /PRNewswire/ — La Academia Europea de Alergia e Inmunología Clínica (EAACI) se complace en anunciar la exitosa conclusión de su esperado Congreso Anual, celebrado … Read more
Lead compounds show remarkable efficacy and safety profiles LAFAYETTE, Calif., June 12, 2023 /PRNewswire/ — Alexander Shulgin Research Institute (ASRI), a pioneering organization in the discovery of next generation psychedelic medicines, announces the identification of two lead compounds currently undergoing late-stage preclinical testing. ASRI plans to disclose further details of their initial lead compounds in a … Read more
IRVINE, Calif., June 12, 2023 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans Keirstead will deliver a keynote at the Digital Innovation Summit, taking place June 12-13 in St. Andrews, New Brunswick, Canada. Hosted by the University of New Brunswick’s McKenna … Read more
НАНЧАН, Китай, 12 июня 2023 г. /PRNewswire/ — С 28 по 30 мая 2023 г. в Нанчане, Китай, прошла 20-я выставка Китайской ассоциации клинической лабораторной практики (CACLP) и 3-я Китайская выставка IVD Supply Chain Expo (CISCE), признанные ведущими выставка диагностики in vitro (IVD) в мире. PR1 На выставочной площади в 130 000 кв. м приняли … Read more
HAMBURG, Germany, June 12, 2023 /PRNewswire/ — The European Academy of Allergy and Clinical Immunology (EAACI) is pleased to announce the successful conclusion of its highly anticipated Annual Congress, held in Hamburg, Germany, from June 9 to 11. The congress brought together a distinguished gathering of leading experts, healthcare professionals, researchers, and industry representatives from … Read more
— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced clinical data for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual … Read more